| Literature DB >> 30717469 |
June-Sung Kim1, Youn-Jung Kim2, Seung Mok Ryoo3, Chang Hwan Sohn4, Shin Ahn5, Dong Woo Seo6, Kyoung Soo Lim7, Won Young Kim8.
Abstract
(1) Background: Septic shock survivors frequently readmit because of subsequent infection. This study aimed to determine the rate and risk factors for same pathogen sepsis readmissions following hospitalization for septic shock. (2)Entities:
Keywords: hospital readmission; outcomes; risk factors; septic shock; survivor
Year: 2019 PMID: 30717469 PMCID: PMC6406311 DOI: 10.3390/jcm8020181
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.241
Figure 1Flowchart of the study population.
Characteristics of Patients with Recurrent Sepsis
| Characteristics | Sepsis due to a Different Organism | Sepsis due to Unknown Organism | Sepsis due to the Same Organism | |
|---|---|---|---|---|
| Age | 65 (59–72) | 54 (57–71) | 64 (68–72) | 0.215 |
| Male | 38 (59.3) | 92 (65.2) | 31 (44.9) | 0.027 |
| Hypertension | 22 (34.4) | 46 (32.6) | 31 (44.9) | 0.308 |
| Stroke | 7 (10.9) | 15 (10.6) | 2 (2.9) | 0.299 |
| Diabetes | 18 (28.1) | 39 (27.7) | 19 (27.5) | 1.000 |
| Coronary artery disease | 11 (17.2) | 19 (13.5) | 5 (7.2) | 0.478 |
| Chronic pulmonary disease | 13 (20.3) | 37 (26.2) | 13 (18.8) | 0.357 |
| Chronic renal failure | 4 (6.3) | 8 (5.7) | 7 (10.1) | 0.055 |
| Liver cirrhosis | 8 (12.5) | 25 (17.7) | 18 (26.1) | 0.738 |
| Malignancy | 49 (76.6) | 116 (82.3) | 58 (84.1) | 0.898 |
| 28 d mortality | 2 (3.1) | 3 (2.1) | 1 (1.4) | 1.000 |
| 90 d mortality | 3 (4.7) | 8 (5.7) | 5 (7.2) | 0.839 |
| Mechanical ventilation | 6 (9.4) | 6 (4.3) | 2 (2.9) | 0.299 |
| ICU stay | 0 (0–3) | 0 (0–2) | 0 (0–3) | 0.608 |
| Same site | 37 (57.8) | 98 (69.5) | 62 (89.9) | 0.001 |
Data are presented as n (%) or median with interquartile ranges.
Characteristics of Causal Organisms.
| Characteristics | Total (%) | Different Organism (%) | Unknown Organism (%) | Same Organism (%) | |
|---|---|---|---|---|---|
|
| |||||
| Gram-positive | 34 (12.4) | 22 (34.3) | 10 (7.1) | 2 (2.9) | 0.001 |
| Gram-negative | 181 (65.8) | 46 (71.8) | 69 (48.9) | 66 (95.7) | <0.001 |
| Viral | 13 (4.7) | 3 (4.7) | 10 (7.1) | 0 (0.0) | 0.069 |
| Fungi | 4 (1.5) | 1 (1.6) | 2 (1.4) | 1 (1.4) | 1.000 |
|
| |||||
| Urinary | 47 (17.1) | 13 (20.3) | 10 (7.1) | 24 (34.8) | <0.001 |
| Gastrointestinal | 43 (15.7) | 10 (15.6) | 17 (12.1) | 16 (23.2) | 0.153 |
| Hepatobiliary | 103 (37.6) | 22 (34.4) | 61 (43.3) | 20 (29.0) | 0.153 |
| Respiratory | 72 (26.3) | 25 (39.1) | 44 (31.2) | 3 (4.3) | 0.165 |
| Skin and soft tissue | 10 (3.6) | 4 (6.3) | 4 (2.8) | 2 (2.9) | 0.638 |
| Other | 29 (10.6) | 8 (12.5) | 15 (10.6) | 6 (8.7) | 0.061 |
Frequencies of Infectious Organisms in the Same Organism Group (n = 69).
| Type | Organisms | Frequency (%) |
|---|---|---|
| Blood |
| 3 (8.1%) |
| Hemolytic streptococci | 1 (2.7%) | |
|
| 19 (51.4%) | |
| 6 (16.2%) | ||
|
| 2 (5.4%) | |
|
| 2 (5.4%) | |
| Other Gram-negatives | 2 (5.4%) | |
| 1 (2.7%) | ||
|
| 1 (2.7%) | |
| Urine |
| 1 (2.7%) |
| Other Gram-positives | 1 (2.7%) | |
|
| 8 (21.6%) | |
|
| 2 (5.4%) | |
| Pneumococci urine Ag | 1 (2.7%) | |
| Sputum | β-hemolytic | 1 (2.7%) |
|
| 1 (2.7%) | |
|
| 1 (2.7%) | |
|
| 2 (5.4%) | |
| Pus |
| 1 (2.7%) |
|
| 4 (10.8%) | |
| 1 (2.7%) | ||
| Stool | 1 (2.7%) | |
|
| 1 (2.7%) |
Abbreviations: spp. = species, Ag = antigen.
Multivariate Analysis for Same Organism Reinfection in Study Patients
| Variables | Multivariate Analysis | ||
|---|---|---|---|
| OR | 95% CI | ||
| Male | 0.589 | 0.295–1.176 | 0.133 |
| Same site | 6.894 | 2.390–19.886 | <0.001 |
| Gram-positive | 0.194 | 0.037–1.016 | 0.052 |
| Gram-negative | 9.902 | 2.843–34.489 | <0.001 |
| UTI | 4.331 | 1.723–10.882 | 0.002 |
| Respiratory | 0.312 | 0.086–1.133 | 0.077 |
Abbreviations: OR = odds ratio; CI = confidence interval; UTI = urinary tract infection.
Performance Parameters for Predictors of Same Organisms in Study Patients
| Variables | Sensitivity (%) | Specificity (%) | PPV (%) | NPV (%) | PLR | NLR |
|---|---|---|---|---|---|---|
| Same site | 89.86 (80.21–100.00) | 33.50 (30.00–40.00) | 31.16 (28.54–33.90) | 90.79 (82.64–95.33) | 1.35 (1.19–1.53) | 0.30 (0.15–0.63) |
| Gram-negative | 95.65 (87.82–100.00) | 44.17 (40.00–50.00) | 36.46 (33.48–39.56) | 96.81 (90.85–98.93) | 1.71 (1.50–1.95) | 0.10 (0.03–0.30) |
| UTI | 34.78 (23.71–40.00) | 88.83 (80.00–90.00) | 51.06 (38.69–63.30) | 80.26 (77.27–82.95) | 3.12 (1.88–5.15) | 0.73 (0.61–0.88) |
| Any of two factors | 24.64 (15.05–30.00) | 96.60 (80.00–100.00) | 70.83 (51.26–84.87) | 79.28 (76.94–81.45) | 7.25 (3.14–16.74) | 0.78 (0.68–0.89) |
| All three factors | 95.65 (87.82–100.00) | 55.34 (0.00–100.00) | 41.77 (37.94–45.71) | 97.44 (92.58–99.14) | 2.14 (1.82–2.51) | 0.08 (0.03–0.24) |
Abbreviations: PPV = positive predictive value; NPV = negative predictive value; PLR = positive likelihood ratio; NLR = negative likelihood ratio; UTI = urinary tract infection. Data are presented with a 95% confidence interval.